Nexstim Oyj - Asset Resilience Ratio
Nexstim Oyj (NXTMH) has an Asset Resilience Ratio of -2.13% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read NXTMH total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2022)
This chart shows how Nexstim Oyj's Asset Resilience Ratio has changed over time. See Nexstim Oyj free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Liquid Assets Composition Over Time
This chart breaks down Nexstim Oyj's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Nexstim Oyj asset portfolio.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €-217.26K | -2.13% |
| Total Liquid Assets | €-217.26K | -2.13% |
Asset Resilience Insights
- Limited Liquidity: Nexstim Oyj maintains only -2.13% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Nexstim Oyj Industry Peers by Asset Resilience Ratio
Compare Nexstim Oyj's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
MicroPort Endovascular MedTech Ltd
SHG:688016 |
Medical Devices | 18.30% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351 |
Medical Devices | 49.23% |
|
Synektik S.A.
WAR:SNT |
Medical Devices | 0.00% |
|
Shanghai Sanyou Medical Co Ltd
SHG:688085 |
Medical Devices | 7.69% |
Annual Asset Resilience Ratio for Nexstim Oyj (2021–2022)
The table below shows the annual Asset Resilience Ratio data for Nexstim Oyj.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2022-12-31 | -2.13% | €-217.26K ≈ $-254.01K |
€10.21 Million ≈ $11.94 Million |
-2.13pp |
| 2021-12-31 | 0.00% | €0.99 ≈ $1.16 |
€10.04 Million ≈ $11.74 Million |
-- |
About Nexstim Oyj
Nexstim Plc, a medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company's transcranial magnetic stimulation (TMS) is a non-invasive neuromodulation technique whereby pulses of electromagnetic fields target and interact with specific brain regions from outside the head. It provi… Read more